Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Deals
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient…
Commercial
Albireo Spotlights Global Patient Communities on Rare Disease Day Nasdaq:ALBO
Deals
Assembly Biosciences and Arbutus Biopharma Initiate Phase 2 Clinical Trial of…
Deals
EMA issues advice on casirivimab and imdevimab antibody cocktail for the…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Deals
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient…
Deals
Amneal Reports Fourth Quarter and Full Year 2020 Financial Results
Deals
Incyte Announces the Validation by the European Medicines Agency of its…
Deals
Assembly Biosciences and Arbutus Biopharma Initiate Phase 2 Clinical Trial of…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Deals
Abcam to Report Interim Results on Monday, March 8, 2021
Deals
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient…
Deals
Amneal Reports Fourth Quarter and Full Year 2020 Financial Results
Commercial
Albireo Spotlights Global Patient Communities on Rare Disease Day Nasdaq:ALBO
Home
Commercial
Deals
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Deals
Deals
Abcam to Report Interim Results on Monday, March 8, 2021
Biospace News
-
March 8, 2021
Deals
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient self-testing using nasal swabs in Germany Swiss Stock Exchange:RO
Globenewswire News
-
February 26, 2021
Deals
Amneal Reports Fourth Quarter and Full Year 2020 Financial Results
Biospace News
-
February 26, 2021
0
Deals
Incyte Announces the Validation by the European Medicines Agency of its...
Biospace News
-
February 26, 2021
0
Deals
Assembly Biosciences and Arbutus Biopharma Initiate Phase 2 Clinical Trial of...
Globenewswire News
-
February 26, 2021
0
Deals
Cronos Group Reports 2020 Fourth Quarter and Full-Year Results Toronto Stock...
Globenewswire News
-
February 26, 2021
0
Deals
EMA issues advice on casirivimab and imdevimab antibody cocktail for the...
Globenewswire News
-
February 26, 2021
0
1
2
3
...
283
Page 1 of 283
- Advertisement -
LATEST NEWS
China’s ZBD to Sell Indian Biological E.’s Superbug Drug in China ...
Firstwordpharma News
-
March 2, 2020
0
Neurotrope Completes Enrollment Of Confirmatory Phase 2 Study of Bryostatin-1 in Moderate to Severe Alzheimer’s Disease
March 13, 2019
GemVax announced phase II results of GV1001 for Alzheimer’s disease treatment at CTAD 2019
December 11, 2019
MUST READ
Anixa Biosciences’ CAR-T Cancer Therapy Receives Intention to Grant Notice from the European Patent...
Biospace News
-
July 10, 2020
0
Daiichi Sankyo Announces New Data on Once-Daily LIXIANA (edoxaban) to be Presented in Late-Breaking...
Firstwordpharma News
-
March 13, 2019
0
Antares Pharma Announces Two Poster Presentations at the 2019 Sexual Medicine Society Scientific Annual...
Biospace News
-
October 24, 2019
0
Load more
